RankingsPricing
  1. JP-listed companies
  2. ROHTO PHARMACEUTICAL CO.,LTD.
  3. Financials
  4. Cost of revenue

ROHTO PHARMACEUTICAL CO.,LTD.【JP:4527】

Market cap
¥611.2B
P/E ratio
18.3x
SummaryFinancialsDividendsHistorySegmentsOwnershipWorkforce
Period EndCost of revenue (Million JPY)YoY (%)
Mar 31, 2025133,686+17.73%
Mar 31, 2024113,554+12.16%
Mar 31, 2023101,243+21.75%
Mar 31, 202283,157+11.88%
Mar 31, 202174,326+0.26%
Mar 31, 202074,135+0.12%
Mar 31, 201974,048+4.67%
Mar 31, 201870,746+11.84%
Mar 31, 201763,254-5.94%
Mar 31, 201667,250+9.54%
Mar 31, 201561,395

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)